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IMMUNE COMPLEX DISEASES* 
FRANK J . DIXON, M.D. 
T h e essential feature of immune complex dis-
eases is that they are caused by antigen- ant ibody 
complex es formed in the circulation or in intersti-
tial flui ds . Complexes so formed are for the most 
part t a ken up and catabolized to harmless end 
products by reticuloendothelial phagocytes and 
blood l e ukocytes, but a small fraction eludes 
these c ells and tends to accumulate in filtering 
struct ures throughout the body such as glomeruli 
and blo od vessels where they can cause injury. 
This a c c umulation is apparentl y determined by 
ana tomic and phys iologic, not immunologic, fac -
tors so that the sites of injury or disease need 
have n o immunologic relationship to the causa-
tive ant igen or an t ibody. In this respec t, immune 
comple x disease is quite different from the "ant i-
tissu e a ntibody" type immunologic disease in 
which the subject ma kes ant ibody specifica lly 
reactive wit h an a nt igenic component of the 
targe t o r di seased tissue and the distribut ion of 
the t issu e-fixed ant igen determines the location 
of the disease. Further, immune complex diseases 
may inv olve mul t iple sites or t issues depending 
upon p h ysical and biologic characteristics of the 
complexes and loca l permeabili ty factors in the 
fi ltering structures . 
The p athogenici ty of immune complexes is in 
large p a rt determined by their a ntigen- an t ibody 
ratio, i .e ., s ize, and the biologic propett ies of their 
antibo d y. Complexes formed in ant ibody excess 
tend to be insoluble and are rapidly phagocy-
tosed, do not circula te, and have li t tle opportu-
nity t o a ccumulate in fil tering sites . Complexes 
form e d in ext reme antigen excess, i.e., antibody-2 
ant igen , are us ua lly too sma ll to become trapped 
in physiologic filters and, fur ther, such antigen 
excess complexes do not conta in an a rrangement 
of immunoglobulin molecules capable of comple-
men t (C) activation . Also essen t ia l in C activa-
tion i s t he nature of the an t ibody in the complex 
since some antibodies are capable and others in -
capable of C activa tion. While the immunochem-
ical cha racter of the ant igen does not seem to be 
an impo rta nt factor in phlogogenicity, the size of 
the a n t i gen may play a role since large prote in 
mole cules and even virions themselves acting as 
antig ens would of necessity result in large nonfil -
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terable ant igen- ant ibody complexes regard less of 
an tigen- ant ibody ratio . 
Most of our knowl edge of the pathogenic mech-
anisms in immune compl ex disease has derived 
from the study of experimen ta l a nd clini ca l 
serum sickness. These diseases resul ting from a 
single la rge injection of fo reign serum protein are 
acute phlogogeni c, mul t isystem di sorde rs in -
vo lving blood vesse ls, heart , kidneys, lymphoid 
tissue, skin , and joints, resembling in pa rt acute 
glomerul onephri t is, rheumat ic feve r, systemic 
lupus erythe matosus, polyarteri t is, and rheuma-
toid art hri t is [1) . Throuah the use of isotope-la-
bell ed bovine serum a lbu min (BSA) as ant igen in 
rabbits, it was possible to quantitate the various 
immunologic events involved in this di sease [2 ). 
As indicated in the F igure the immune response 
to BSA in the rabbit is indicated by the rapid 
te rmina l elimination of ·t he circulating antigen 
beginning 11 days a fte r injection. T he fate of cir-
cula ting serum protein ant igen is characteri zed 
by an ini t ial two-day peri od during which the an-
tigen equilibrates between int ravascular a nd ex-
travascular spaces fo llowed by a slower rate of 
loss, lasting a li t tl e more than a week, during 
which t he ant igen is catabolized nonimmunolog-
ically, and finally by a ra pid termina l immune 
elimination. Measurement of circulating an tigen-
ant ibody complexes indicates their appea rance on 
day 8 short ly before immune elimination begins 
and their increase during the following 2- 3 days. 
Coincident with the increase of circulating com-
plexes and the beginning of immune elimination 
is a fall in the serum C to levels half normal. P re-
sumably, as antibody is fo rmed and com plexes 
in crease in size and amount, they a re capable of 
reacting wi th serum C whi ch in turn increases the 
size of the complexes and makes them more 
readily phagocytosed , t hereby hastening t heir 
elimination. The importance of immune complex 
size is illustrated by the fact t hat only rabbits 
wi th circulating complexes greater than 19s in 
size developed signifi cant serum sickness [3]. 
Once the antigen is eliminated, free antibody 
appears in the circulation. Simul taneously with 
the appearance of circulating complexes the clin -
ica l and histologic mani festations of serum sick-
ness develop. Following elimination of circulating 
complexes the serum sickness di minishes. If t he 
immune complexes are t ruly the etiologic agent of 
this disease, one would expect to find them in the 
lesions themselves and this has been done ut i-
li zing t he flu orescent a n t ibody tec hni que [2 ). 
BSA, host immunoglobulin, and host C have all 
been detected in diseased glomeruli and in sites 
of arteri t is. 
These immunologic d eve lopments t rigger a 
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FIGURE. Dynamics of the immune response following 
injection of I' "- labelled BSA in rabbi ts. 
number of secondary humoral and cellular events 
capable of mediating an inflammatory response . 
As the complexes form t hey act upon basophils 
probably via homocytotropic antibod ies and, as a 
result of this, platelets, t he major reservoir of his-
tamine and serotonin in the rabbit, are clumped 
and otherwise affected to liberate these sub-
stances. This systemic liberation of vasoactive 
substances is essential for the subsequent locali -
zation of complexes in various parts of the vas-
cu lar bed, presumably by increasing vascular 
permeability, and the loca li zation can be blocked 
by antihistamines and antiserotonins . As the 
complexes begin to localize in glomeruli , arteries, 
etc. , they a lso activate C, and the C-derived 
chemotactic factors attract polymorphonuclear 
(PMN) leukocytes which release thei r proteolytic 
enzymes and basic proteins causing loca l t issue 
destruction. Complexes a lso cause endothelial 
proliferation, a prominent aspect of the glomer-
ular response in acute serum sickness. Since de-
pletion of C and PMN in an ima ls subjected to 
serum sickness wi ll not completely suppress the 
associated glomeru lonephri tis, it seems that com-
plexes can a lso cause damage in the sites in wh ich 
they localize by C and PMN independent routes, 
the nature of which is not yet well understood [4]. 
A chronic form of serum sickness clinically 
more similar to the spontaneous human serum 
sickness-like diseases can be produced by daily 
injections of re latively small amounts of foreign 
serum proteins into rabbits (5] . Properly executed 
this procedure results in the presence of circu-
lating complexes for at least severa l hours every 
day. Such rabbits develop a chronic membranous 
or necrotizing glomerulonephritis morphologically 
distinct from the acute proliferative glomerulone-
phritis occuring in one-sh.ot serum sickness . The 
antigen- antibody system and the pathways of 
mediation of inflammation, etc. appear to be sim-
ilar in both kinds of serum sickness so the differ-
ence in morphologic expression of disease is pre-
sumably related to the quantitative and temporal 
aspects of exposure to immune complexes, a fact 
worth remembering when trying to relate partic-
ular human disease patterns to certain types of 
antigen- antibody complexes. 
Our understanding of the role of immune com-
plexes in serum sickness is reasonably complete 
because the antigen is known and can be traced 
via isotopic and immunofluorescent techniques, 
thereby making possible detailed observation of 
formation and fate of the complexes. In most 
human diseases of suspected immune complex 
pathogenesis, the antigen is not known and the 
search for immune complexes is far from direct so 
suspicions are based on indirect and/or circum-
stantial evidence. The first suggestion of immune 
complex pathogenesis in human disease was 
based on the clinical and histopathologic similari-
ties of serum sickness on one hand and glomeru-
lonephritis, rheumatic fever, systemic lupus ery-
thematosus, rheumatoid arthritis, and var ious 
vasculid ites on the other. This relationship was 
postulated even before t he pathogenesis of serum 
sickness was well understood. Immunologic and 
physical attempts to demonstrate circulating 
immune complexes have provided suggestive evi-
dence of their presence in some patients with 
rheumatoid arthri tis, systemic lupus erythemato-
sus, hyperglobulinemic purpura, and Australia 
antigen infections. Among the more successful 
techniques employed in the demonstration of cir-
culating immunoglobu lin contain ing complexes 
possibly antigen- antibody in nature are: (1) ana-
lytic ultracentrifugation-a quantitative but rela-
t ively insensitive procedure which gives a mea-
surement of size as well as amount of protein 
complexes, (2) cryoprecipitation-an eas ily per-
formed, often quite sensitive means of separating 
complexes with temperature-related solubil ity, (3) 
reaction with the Clq component of complement 
-a reaction capable of detecting immunoglobulin 
containing complexes as well as other possible 
serum constituents such as DNA and endotoxin 
[6], and (4) reaction with lgM rheumatoid factor 
-selected rheumatoid factors will react with 
small amoun ts of immunoglobu lin containing 
complexes, particularly t hose found in rheuma-
toid patients [7] . 
The best understood of the various immune 
complex diseases is systemic lupus erythematosus 
[8 ]. In this disease there are multiple antibodies 
reactive with a variety of cellular antigens of the 
host. Best known are the diagnostic antinuclear 
and particularly ant i-DNA antibod ies. In the 
course of lupus some of these cellular antigens are 
detectable in the serum (antigen excess) and at 
other t imes free antibodies to t hese antigens are 
present (antibody excess) . During sh ifts from an-
tigen to antibody excess and vice versa, immune 
complexes would of necessity be present in the 
serum, a situation very s imilar to that in serum 
sickness. These complexes may be evidenced by 
cryoprecipitates or positive Clq reactions. As 
would be expected, whil e immune complexes cir-
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culate , t he ma ni fes tations of disease worsen. 
These complexes de posit in glomeruli and larger 
blood vessels assoc iated wit h the most serious 
manifesta t ions of thi s disease, glomerulonephri t is 
and vasculi t is. Rena l biopsy has been extre mely 
valua bl e in the stud y of this kidney disease. Nu-
clea r (DNA) a ntigen s have been found in diseased 
glom e ruli as well as host immunoglobulin a nd 
comple m ent . In addit ion, antinuclea r (DNA) a n-
tibodies have been eluted from the kidn eys of 
lupus patients . Thus, a ll of t he components of 
immune complexes have been ident ified in the 
diseased orga ns. 
The other disease with a reasonably well dem-
onstrated immune complex pa thogenesis is glom -
erulon e phrit is. About 95 per cent of glomerulone-
phrit i s a ppea rs to be associated wit h immune 
com plex deposition in the glomeruli and 5 per 
cen t is caused by a ntibodi es formed aga inst a nti-
gens f ixed in the glomerular basement membra ne. 
Im mune complexes deposit in a charact eristic 
pattern in glomeruli , irregular granular to lumpy 
agregates along the glomerular base ment mem -
branes. Thus, when host immunoglobulin and 
complement a re found in this distribut ion, it is 
stron g p resumpti ve · ev idence for immune com-
plexe s e v en if the nature of the an t igen is not 
known. I n immune complex glomerulonephrit is a 
nu mber of differen t a nt igens have been found 
cap a ble of forming nephri togenic complexes . In 
addition to the nuclear antigens in sys temic lupus 
ther e a r e: streptococcal ant igens in acute post 
strep tococca l glome rulonephri t is, malaria l a nti -
gen s in t he nephrosis accompanying quarta n ma-
laria , staphylococca l a ntigens in the nephri t is 
accompanying infected vent riculoatrial shunts fo r 
hydrocephalus, Australia an tigen in nephritis a nd 
vasculit i s accompanying infection wi th this agent, 
and t h y roglobulin in nephri t is associated with 
autoimmune thyroiditis. However, taken together 
these r ecogni zed an tigens account for a sma ll 
prop o r t i o n of all immune complex glomerulone-
phritis. The great variety of a ntigens capable of 
caus ing this s ingle disease via a single pathoge-
neti c mechanis m illustrates the an tige nic nonspe-
cific ity o f immune complex disease. 
In a sense, our study of glomerulonephri t is has 
turne d up many more instances of immune com-
plex dis e ase t han we have an t igens to accoun t for 
the m a nd has prompted a search for other etio-
logic agents. Exa mination of sp ontaneous im-
mune c omplex diseases of animals finds many, 
perha p s most, of t hem associated with chronic 
viral infections. In these chronic infections vi-
remia i s the rule, and commonly t he viruses 
themsel v es and perhaps soluble viral p roducts 
serve as antigens to form circula ting immune 
comple x es . Thi s situa tion has been found in 
chroni c infec ti ons wi t h t he fo llowing viruses: 
lymphochori omeningit is, lacticdehydroge nase, 
Gross, Rauscher, Friend, Aleut ian, a nd the agen t 
of equine infectious anemia . Indeed, in the well -
stud ied N ZBxW mice wi th a lupus-like disease, 
not only a re there nuclear ant igens involved in 
immune complex formation but also ant igens de-
rived from t he Gross- like virus which infects 
them. Thus, in these animal models of human 
lupus at least two kinds of an t igen- an tibody sys-
te ms are s imulataneously forming immune com -
plexes which a re deposit ing in glomeruli a nd 
causing nephri t is. The sea rch for similar viruses 
which may be involved in human immune com -
plex disease has just begun, and one virus, Aus-
t ralia a ntigen, has been shown to form circulating 
complexes wi th immunoglobulin a nd to deposit in 
glomeruli associa ted with the development of 
nephri t is. 
From t his discussion it is apparent that im-
mune complexes are a common mea ns by which 
immunologic diseases are mediated . T he facts 
that a single kind of ant igen- ant ibody complex 
may induce disease in a vari ety of t issues and 
organs, as in serum sickness; that a large number 
of diffe rent ant igens may be able to form com-
plexes all capable of causing a similar disease, as 
wi th the mul t iple agents involved in im mune 
complex glomerulonephri tis; and that mul ti ple 
antige n- a ntibody systems may be found part ici-
pating s imul ta neously in immune complex fo rma-
tion, as in NZBxW mice and patients with sys-
te mic lupus erythematosus, indicate the pathoge-
netic complexity of these disorders. However, 
now that some of t he immunologic characteristics 
of t hese diseases are being recognized, the search 
for causal agents should yield resul ts and then 
some rationa l immunotherapy and perhaps even 
immunoprophylaxis may be possible. 
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